Current status:
Cancelled Pre Market
Current status date:
2017-08-01
DIN:
02237428
Electronic product monograph is not available
Company:
PHARMACHEMIE B.V.
Swensweg 5, Po Box# 552
Haarlem
North Holland
Netherlands
2003 RN
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
Anatomical Therapeutic Chemical (ATC):
See footnote 4
L01CB01 ETOPOSIDE
List of active ingredient(s)
Active ingredient(s)
See footnote8
|
Strength |
ETOPOSIDE
|
20 MG / ML
|